Skip to main navigation

About Us
- Leadership
- Contact
Technology
Pipeline
- Proprietary Programs
- Partnered Programs
Patients
Clinical Trials
Collaborations
Investors + Media
Careers

About Us
- Leadership
- Contact
Technology
Pipeline
- Proprietary Programs
- Partnered Programs
Patients
Clinical Trials
Collaborations
Investors + Media
Careers

News Releases

Investors + Media
- Corporate Profile
- Email Alerts
Stock Information
News Releases
Events + Presentations
Financials + SEC Filings
Corporate Governance

News Releases

Year

Jan 04, 2019

Sangamo Therapeutics To Present at the 37th Annual J.P. Morgan Healthcare Conference

RICHMOND, Calif., Jan. 4, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that Sandy Macrae , CEO of Sangamo, will present a corporate overview at the 37 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9 th at 11:30 a.m. PT in San Francisco . Dr.

Additional Formats

PDF Version

Jan 04, 2019

Sangamo Announces Upcoming Clinical Data Presentations At WORLDSymposium 2019

RICHMOND, Calif., Jan. 4, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that interim clinical data from the Company's inherited metabolic diseases development programs will be presented at WORLD Symposium , an annual conference dedicated to lysosomal diseases being

Additional Formats

PDF Version

Pagination

Previous page
Page 1
Current page 2

Displaying 11 - 12 of 12

© Sangamo Therapeutics

Disclaimer
Privacy Policy